In HNSCC, TERT promoter mutations are moderately frequent (range 17–32%) (55, 56) compared to melanoma, glioblastoma, and bladder cancer (57), but more frequent in recurrent vs. non-recurrent squamous cell carcinoma of the oral cavity (58). This evidence concerns the gene TERT and urinary bladder cancer.